Tapewire

Nasdaq · USD

NRSN

NeuroSense Therapeutics Ltd.

Export transactions ↓
Tapewire entity
7767
SEC CIK
0001875091
Parsed reports
15

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202620
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 16, 2026 Filed Jun 17, 2026 20:30 UTC
Ben-Noon AlonChief Executive Officer
PurchaseOrdinary Shares 250,000 $0.80 $200,000.00
Disclosure

SEC source: 0001213900-26-069663 · ownership.xml · nonDerivative · entry 1

Ben-Noon Alon · CIK 0001901198 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,534,233

F1 · security: On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.

Read SEC document
June 16, 2026 Filed Jun 17, 2026 20:30 UTC
Eisenberg OrChief Financial Officer
PurchaseOrdinary Shares 250,000 $0.80 $200,000.00
Disclosure

SEC source: 0001213900-26-069662 · ownership.xml · nonDerivative · entry 1

Eisenberg Or · CIK 0001721412 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,504,050

F1 · security: On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.

Read SEC document
March 26, 2026 Filed Mar 30, 2026 21:32 UTC
Russek-Blum NivaChief Technology Officer
GrantOrdinary Shares 200,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-036432 · ownership.xml · nonDerivative · entry 1

Russek-Blum Niva · CIK 0002124437 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 467,953

F1 · security: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee or director in connection with the Issuer's 2018 Share Incentive Plan must be registered in the name of a trustee.

F2 · shares: The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Read SEC document
March 26, 2026 Filed Mar 30, 2026 12:49 UTC
Binder HagitGeneral Manager
GrantOrdinary Shares 200,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-036022 · ownership.xml · nonDerivative · entry 1

Binder Hagit · CIK 0002118272 · General Manager

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 521,806

F1 · security: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee or director in connection with the Issuer's 2018 Share Incentive Plan must be registered in the name of a trustee.

F2 · shares: The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Read SEC document
March 26, 2026 Filed Apr 1, 2026 20:26 UTC
Eisenberg OrChief Financial Officer
GrantOrdinary Shares 200,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-038545 · ownership.xml · nonDerivative · entry 1

Eisenberg Or · CIK 0001721412 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,254,050

F1 · shares: The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.